This page is part of the US Public Health Profiles Library (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
{
"resourceType" : "MedicationAdministration",
"id" : "us-ph-medicationadministration-eve-everywoman-naloxone-response",
"meta" : {
"versionId" : "2",
"lastUpdated" : "2022-07-21T22:24:10.019+00:00",
"source" : "#rfdCh1ZhXm3LPmQY",
"profile" : [
"http://hl7.org/fhir/us/ph-library/StructureDefinition/us-ph-medicationadministration"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration \"us-ph-medicationadministration-eve-everywoman-naloxone-response\" Version \"2\" Updated \"2022-07-21 10:24:10+0000\" </p><p style=\"margin-bottom: 0px\">Information Source: #rfdCh1ZhXm3LPmQY!</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-us-ph-medicationadministration.html\">US Public Health MedicationAdministration</a></p></div><p><b>US Public Health Therapeutic Medication Response Extension</b>: Patient's condition improved (finding) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#268910001)</span></p><p><b>status</b>: completed</p><p><b>medication</b>: naloxone HCl 0.4 MG in 1 ML Injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1659929)</span></p><p><b>subject</b>: <a href=\"Patient-us-ph-patient-eve-everywoman.html\">Patient/us-ph-patient-eve-everywoman: Eve Everywoman</a> \" EVERYWOMAN\"</p><p><b>effective</b>: 2018-03-07 --> 2018-03-07</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Gluteus maximus muscle <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#206007)</span></td><td>Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></td><td>1 mL<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mL = 'mL')</span></td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/us/ph-library/StructureDefinition/us-ph-therapeutic-medication-response-extension",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "268910001",
"display" : "Patient's condition improved (finding)"
}
]
}
}
],
"status" : "completed",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1659929",
"display" : "naloxone HCl 0.4 MG in 1 ML Injection"
}
]
},
"subject" : {
"reference" : "Patient/us-ph-patient-eve-everywoman",
"display" : "Eve Everywoman"
},
"effectivePeriod" : {
"start" : "2018-03-07",
"end" : "2018-03-07"
},
"dosage" : {
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "206007",
"display" : "Gluteus maximus muscle"
}
]
},
"method" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}
]
},
"dose" : {
"value" : 1,
"unit" : "mL",
"system" : "http://unitsofmeasure.org",
"code" : "mL"
}
}
}